It's looks like this piece of crap will come back on market at around pre first offer price. After the damage Toad has done to the share price, who's going to be stupid enough to buy in.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come